A major breakthrough in cancer treatment has just taken place in Rouen, where the Centre Henri-Becquerel has tested a next-generation radiotherapy machine for the very first time. Its name: Ethos — and it could redefine how tumors are treated.

🎯 Targeting Cancer with Real-Time Precision
Unlike traditional radiotherapy systems, Ethos uses artificial intelligence to visualize the tumor in real time during each session. This allows doctors to adjust the radiation dose instantly, adapting to subtle anatomical changes and ensuring that cancer cells are precisely targeted.

🛡️ Protecting Healthy Tissue
One of the most promising aspects of this innovation is its ability to better spare surrounding healthy tissues. By recalculating and optimizing the treatment plan at every appointment, the system aims to minimize collateral damage — a key factor in reducing side effects.

👨‍⚕️ First Focus: Prostate Cancer
Initially deployed for prostate cancer patients, the technology is designed to improve comfort, safety, and long-term outcomes. Fewer side effects could mean a significantly better quality of life during and after treatment.

🌍 A Glimpse Into the Future of Oncology
The introduction of AI-driven radiotherapy marks a turning point in modern oncology. With smarter machines assisting medical teams, cancer care is entering an era where treatment is not only powerful — but increasingly personalized.

In Rouen, a new chapter in the fight against cancer has just begun.